Remedy

Remedy's performance across various categories in Nevada shows a mix of both promising growth and areas for improvement. In the Concentrates category, Remedy has seen notable fluctuations, ranking 21st in March 2024 and then reappearing in 16th place by May 2024, before dropping out of the top 30 in April and June. This indicates a potential for volatility in this segment. The Flower category also shows some inconsistency, with Remedy peaking at 41st in March 2024, dropping to 64th in April, then climbing back to 45th in May before settling at 52nd in June. Despite this, the sales figures for Flower remain relatively robust, suggesting that while the brand may not always be in the top ranks, it maintains a steady consumer base.

The Pre-Roll category tells a similar story of fluctuating rankings. Remedy was ranked 44th in March 2024, improved to 40th by May, but then fell to 54th in June. This volatility suggests that while Remedy has a presence in the Pre-Roll market, it struggles to consistently stay within the top tiers. In the Vapor Pens category, Remedy appeared in the rankings only in March, at 55th place, and did not make it into the top 30 for the subsequent months. This indicates a weaker performance in the Vapor Pens segment, which could be a potential area for strategic improvement. Overall, while Remedy shows potential in certain categories, the brand's performance is marked by significant fluctuations and areas where it fails to maintain a top 30 position consistently.